This compound is primarily used as an intermediate in the synthesis of antibacterial agents, particularly fluoroquinolone antibiotics. Its structure is key to developing drugs that target bacterial DNA gyrase and topoisomerase IV, enzymes critical for bacterial DNA replication. The compound’s modifications enhance its ability to penetrate bacterial cells and improve its efficacy against a broad spectrum of pathogens, including both Gram-positive and Gram-negative bacteria. It is particularly valuable in creating medications for treating respiratory, urinary tract, and skin infections. Its role in drug development contributes to addressing antibiotic resistance by providing a foundation for novel therapeutic options.